ExploreWatchlistsPricing
  1. JP-listed companies
  2. TERUMO CORPORATION
  3. Financials
  4. Net income margin (%)

TERUMO CORPORATION (4543)

Market cap
¥3.22T
P/E ratio
23.6x
Terumo develops medical devices and solutions for heart treatment, clinical care, and blood technology to support healthcare delivery worldwide.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndNet income margin (%) YoY (%)
Mar 31, 202511.3-2.16%
Mar 31, 202411.5+5.95%
Mar 31, 202310.9-13.76%
Mar 31, 202212.6+0.32%
Mar 31, 202112.6-7.10%
Mar 31, 202013.5+2.21%
Mar 31, 201913.3-14.65%
Mar 31, 201815.5+47.28%
Mar 31, 201710.5+9.26%
Mar 31, 20169.7+22.82%
Mar 31, 20157.9-17.88%
Mar 31, 20149.6-22.59%
Mar 31, 201312.4+112.19%
Mar 31, 20125.8

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat